SCHEDULE: TD Securities Discloses Warrant Holdings in OneMedNet
Beneficial Ownership Filing (Schedule 13G Amendment)
TD Securities (USA) LLC has filed an amended Schedule 13G, reporting beneficial ownership of 292,156 shares of OneMedNet Corporation common stock issuable upon exercise of warrants.
Summary
- TD Securities (USA) LLC (TDS) has filed an amendment to its Schedule 13G, reporting beneficial ownership of 292,156 shares of OneMedNet Corporation common stock.
- These shares are issuable upon the exercise of warrants held by TDS, which have an exercise price of $115.00 per share and are currently exercisable.
- The filing indicates that TDS has sole voting power and sole dispositive power over these shares.
- The reported ownership represents 4.6% of OneMedNet's outstanding common stock, based on 6,012,591 shares outstanding as of September 26, 2026, plus the shares issuable from the warrants.
- This filing is a joint filing by TDS, Toronto Dominion Holdings USA Inc. (TDH), TD Group US Holdings LLC (TD GUS), and The Toronto-Dominion Bank (TD Bank), with TDS being the direct holder of the warrants.
- The other entities (TDH, TD GUS, TD Bank) are deemed to have an indirect interest through ownership of TDS, but disclaim beneficial ownership beyond their pecuniary interest.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a neutral filing, primarily an administrative update regarding beneficial ownership of warrants, with no new financial performance data or strategic shifts.
Positives
- TD Securities (USA) LLC holds exercisable warrants, indicating a potential future stake in OneMedNet.
- The reporting of beneficial ownership is a standard disclosure, ensuring transparency.
Negatives
- The reported shares are not currently owned but are issuable upon warrant exercise, meaning actual ownership is contingent.
- The exercise price of $115.00 per share is significantly higher than the current market price, making immediate exercise unlikely without a substantial price increase.
Risks
- The value of the reported beneficial ownership is directly tied to the future performance of OneMedNet's stock and its ability to reach a share price significantly above the $115.00 warrant exercise price.
- Market volatility could impact the value of the warrants and the underlying shares.
Future Outlook
The filing does not contain forward-looking statements or guidance from the company. The future outlook for the reported shares is contingent on the exercise of warrants, which depends on OneMedNet's stock performance exceeding the $115.00 exercise price.
Management Comments
- TD Securities (USA) LLC has the sole power to vote or direct the vote and the sole power to dispose or direct the disposition of these shares.
- The beneficial ownership is comprised solely of shares issuable upon the exercise of warrants.
- Each of TDH, TD GUS and TD Bank disclaims ownership of the shares reported herein except to the extent of its pecuniary interest therein.
- Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is... acting... as a partnership... or group... or... a member of any group with respect to the Issuer or any securities of the Issuer.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and entities that acquire a significant stake in a company, often through derivative instruments like warrants. This filing indicates a financial institution's interest in OneMedNet, but the nature of warrant ownership suggests a speculative or strategic investment rather than direct operational control.
Comparison to Industry Standards
- This filing is a standard Schedule 13G amendment, typical for institutional investors holding significant positions or potential future ownership through derivatives.
- The 4.6% beneficial ownership via warrants is a common threshold for reporting under SEC rules, indicating a notable but not controlling stake.
- The structure of the filing, with multiple related entities disclaiming direct ownership beyond pecuniary interest, is standard practice for large financial conglomerates like The Toronto-Dominion Bank group to manage reporting obligations.
Stakeholder Impact
- Shareholders: The filing provides transparency on a significant warrant holder, which could be a factor in future stock price movements if warrants are exercised.
- Creditors: No direct impact is indicated.
- Employees: No direct impact is indicated.
- Suppliers: No direct impact is indicated.
- Customers: No direct impact is indicated.
Next Steps
- TD Securities (USA) LLC may exercise its warrants if OneMedNet's stock price increases significantly above $115.00 per share.
- Further amendments to Schedule 13G would be required if beneficial ownership changes significantly.
Key Dates
| Date | Description |
|---|---|
| 2026-09-26 | Date of Issuer's Form 8-K reporting shares outstanding. |
| 2026-09-29 | Date Issuer's Form 8-K was filed with the SEC. |
| 2026-11-13 | Date of the Schedule 13G filing and joint filing agreement. |
Keywords
warrants, beneficial ownership, Schedule 13G, OneMedNet Corporation, TD Securities, shareholder, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.